Benoit Beuselinck

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

Robert J. Motzer, Brian I. Rini, David F. McDermott et al. · The Lancet Oncology · 2019 · 780 citations · Full text

Medicine, Oncology, Pharmacology +12

Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Daniel Y.C. Heng, J. Connor Wells, Brian I. Rini et al. · European Urology · 2014 · 474 citations · Full text

Medicine, Oncology, Surgery +15

Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting

Benoit Beuselinck, Sylvie Job, Étienne Becht et al. · Clinical Cancer Research · 2015 · 300 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival

Shaan Dudani, Guillermo de Velasco, J. Connor Wells et al. · JAMA Network Open · 2021 · 299 citations · Full text

Medicine, Oncology, Pathology +17

<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGS

Melissa C. Southey, Robert Winqvist, Katri Pylkäs et al. · Journal of Medical Genetics · 2016 · 217 citations · Full text

Medicine, Genetics, Molecular Genetics +17